These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 34088954

  • 1. 4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity.
    de Pablo S, Rodríguez-Comas J, Díaz-Catalán D, Alcarraz-Vizán G, Castaño C, Moreno-Vedia J, Montane J, Parrizas M, Servitja JM, Novials A.
    Sci Rep; 2021 Jun 04; 11(1):11878. PubMed ID: 34088954
    [Abstract] [Full Text] [Related]

  • 2. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment.
    Montane J, de Pablo S, Castaño C, Rodríguez-Comas J, Cadavez L, Obach M, Visa M, Alcarraz-Vizán G, Sanchez-Martinez M, Nonell-Canals A, Parrizas M, Servitja JM, Novials A.
    FASEB J; 2017 Dec 04; 31(12):5296-5306. PubMed ID: 28821639
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes.
    Mukherjee N, Contreras CJ, Lin L, Colglazier KA, Mather EG, Kalwat MA, Esser N, Kahn SE, Templin AT.
    Mol Metab; 2024 Feb 04; 80():101877. PubMed ID: 38218538
    [Abstract] [Full Text] [Related]

  • 11. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.
    Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC.
    Diabetes; 1998 May 04; 47(5):743-50. PubMed ID: 9588445
    [Abstract] [Full Text] [Related]

  • 12. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N, Ahrens R, Sabale M, Wu L, Ha K, Verdile G, Fraser PE.
    FASEB J; 2017 Dec 04; 31(12):5409-5418. PubMed ID: 28808140
    [Abstract] [Full Text] [Related]

  • 13. PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice.
    Chen YC, Mains RE, Eipper BA, Hoffman BG, Czyzyk TA, Pintar JE, Verchere CB.
    Diabetologia; 2020 Mar 04; 63(3):561-576. PubMed ID: 31984442
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice.
    Aitken JF, Loomes KM, Riba-Garcia I, Unwin RD, Prijic G, Phillips AS, Phillips ARJ, Wu D, Poppitt SD, Ding K, Barran PE, Dowsey AW, Cooper GJS.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):625-631. PubMed ID: 27865831
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pancreatic β cell-selective zinc transporter 8 insufficiency accelerates diabetes associated with islet amyloidosis.
    Xu J, Wijesekara N, Regeenes R, Rijjal DA, Piro AL, Song Y, Wu A, Bhattacharjee A, Liu Y, Marzban L, Rocheleau JV, Fraser PE, Dai FF, Hu C, Wheeler MB.
    JCI Insight; 2021 May 24; 6(10):. PubMed ID: 34027899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes.
    Kim J, Cheon H, Jeong YT, Quan W, Kim KH, Cho JM, Lim YM, Oh SH, Jin SM, Kim JH, Lee MK, Kim S, Komatsu M, Kang SW, Lee MS.
    J Clin Invest; 2014 Aug 24; 124(8):3311-24. PubMed ID: 25036705
    [Abstract] [Full Text] [Related]

  • 20. Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
    Templin AT, Mellati M, Soininen R, Hogan MF, Esser N, Castillo JJ, Zraika S, Kahn SE, Hull RL.
    Protein Eng Des Sel; 2019 Dec 13; 32(2):95-102. PubMed ID: 31769491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.